| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 1.372 | 5.107 | 8.037 | 13.620 | 20.490 | 29.826 | 82.449 |
| Total Income - EUR | - | - | - | 1.372 | 5.107 | 8.037 | 13.620 | 20.490 | 29.826 | 82.455 |
| Total Expenses - EUR | - | - | - | 11 | 229 | 185 | 708 | 2.280 | 15.308 | 45.592 |
| Gross Profit/Loss - EUR | - | - | - | 1.362 | 4.878 | 7.853 | 12.912 | 18.210 | 14.518 | 36.863 |
| Net Profit/Loss - EUR | - | - | - | 1.320 | 4.725 | 7.612 | 12.504 | 17.595 | 12.195 | 30.965 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
Check the financial reports for the company - Rmc Dermasafe S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 770 | 670 | 572 | 490 | 405 | 13.617 |
| Current Assets | - | - | - | 1.619 | 5.710 | 13.563 | 25.901 | 20.473 | 18.973 | 26.360 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 506 | 496 | 485 | 15.116 | 11.473 | 17.147 |
| Cash | - | - | - | 1.619 | 5.204 | 13.067 | 25.415 | 5.357 | 7.501 | 9.213 |
| Shareholders Funds | - | - | - | 1.363 | 6.062 | 13.559 | 25.762 | 17.636 | 12.235 | 32.206 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 256 | 418 | 675 | 711 | 3.327 | 7.143 | 7.772 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Rmc Dermasafe S.r.l.